Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

Vendor payments not responsible for rising popularity of LAAO procedures
Consulting fees and other vendor payments do not appear to be directly influencing U.S. physicians to implant more Watchman devices. Researcher Alexander Kolomaya, MD, discussed his team's findings on this topic.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Family of heart patient who died awarded $45M after suing health system for negligence
The 55-year-old patient woke up experiencing chest pain one morning and an ambulance was called. He was dead just a few hours later. His family's lawsuit argued that delays in care, communication errors and other issues were directly responsible for his death.
FDA clears new device for enabling access to the heart’s surface without an exposed needle
CardioVia's ViaOne technology includes a blunt-tip needle that remains concealed to help interventional cardiologists and electrophysiologists treat cardiac arrhythmias with a reduced risk of perforation or any other complications.
Choosing left radial access in the cath lab helps cardiologists limit radiation exposure
Using a left radial artery approach in the cath lab exposes interventional cardiologists to significantly less radiation than a hyper-adducted right radial artery approach. The difference is substantial enough for researchers to declare LRA "the primary access site for cardiac catheterization."

How intravascular lithotripsy can improve TMVR outcomes

The IVL technology developed by Shockwave Medical helped clinicians treat a TMVR patient who had previously undergone TAVR. Could this be a common use of IVL in the future?

Medtronic enrolls first patient for head-to-head EVAR study

The randomized trial, expected to enroll at least 550 patients, will follow patients for a total of five years.

Samir Kapadia, MD, Cleveland Clinic TAVR transcatheter aortic valve replacement

Q&A: Discussing TAVR trends with cardiologist Samir Kapadia of Cleveland Clinic

What's next for TAVR? What trends should clinicians be focused on as time goes on? Kapadia shared his perspective in a new interview.

Interventional cardiology specialists raise $20M to continue IVL research

AVS, a Michigan-based medical device company, has said the funding will help accelerate research on its new Pulse P-IVL system. One clinical trial is already underway.

The Shimadzu Trinias SCORE Opera Angiography system at RSNA 2022. It offers dose lowering technologies and workflow efficiencies. #RSNA #RSNA22

VIDEO: Shimadzu lowers dose and speeds workflow with new Trinias SCORE Opera angiography system

Sponsored by Shimadzu

Shimadzu Medical Systems USA released the latest version of its Trinias angiography system at the Radiological Society of North America (RSNA) 2022 meeting to address radiation concerns and to help improve workflow.

Why cardiologists should pay close attention to rehospitalizations after TAVR or SAVR

A new analysis in Circulation: Cardiovascular Interventions examined rehospitalization rates after AVR, noting that they are consistently associated with worse outcomes and a higher risk of patient mortality.

Radiation and workflow concerns addressed in new Shimadzu angiography system

To address radiation concerns by interventionalists and to help speed workflows in cath labs, Shimadzu released new AI features and single button push features for table and C-arm movement.

An example of virtual pulmonary valve implant planning software showing a virtual transcatheter pulmonary valve with measurements implnated in the virtual anatomy of a congenital heart patient. This was part of a training class at the Society of Cardiovascular Computed Tomography (SCCT) 2022 meeting.

FDA makes clearance easier for cardiac device implant simulation software

The FDA is reclassifying interventional cardiovascular implant simulation software into the class II (special controls) regulatory category, which will make it easier for the technology to pass regulatory approval.

Cath Lab

Vendor payments not responsible for rising popularity of LAAO procedures

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Family of heart patient who died awarded $45M after suing health system for negligence

FDA clears new device for enabling access to the heart’s surface without an exposed needle

Choosing left radial access in the cath lab helps cardiologists limit radiation exposure